Sign In
Interview
On a humid May afternoon, seated in his Gurugram residence, Prashant Tandon speaks with the calm assurance of someone who has spent over a decade navigating both regulatory mazes and the challenges of one of the most complex sectors—healthcare.
As the co-founder and CEO of Tata 1mg, Tandon has been the steady hand guiding the company’s transformation from a medicine information app to one of India’s most prominent digital health platforms. This has seen him emerge as one of the most authoritative voices in healthcare.
Since its acquisition by the Tata Group in 2021, 1mg has evolved from an e-pharmacy into a full-stack outpatient healthcare business, offering diagnostics, teleconsultations, private label offerings, rapid medicine delivery, and most recently, offline retail and institutional healthcare.
Already a subscriber? Sign In
Be the smartest person in the room. Choose the plan that works for you and join our exclusive subscriber community.
Premium Articles
4 articles every week
Archives
>3 years of archives
Org. Chart
1 every week
Newsletter
4 every week
Gifting Credits
5 premium articles every month
Session
3 screens concurrently
₹3,999
Subscribe Now
Have a coupon code?
Join our community of 100,000+ top executives, VCs, entrepreneurs, and brightest student minds
Blume Ventures
The CapTable brings a refreshing set of insights for us at the Blume team, highlighting stories that bring together the underlying business and founders with that of investors' journeys with these startups. It's an important perspective that very few bring to startup ecosystem enthusiasts.
Convinced that The Captable stories and insights
will give you the edge?
Convinced that The Captable stories
and insights will give you the edge?
Subscribe Now
Sign Up Now
